|
|
|
Weekly Market: Global chaos drag markets lower for the week
|
|
Friday, December 12, 2014 |
| | | Market Commentary | | | Global chaos drag markets lower for the week | | Indian markets wrapped up the week ended Dec 12, 2014 in the red zone led by weak global environment. The Sensex was down by 3.26% and the Nifty fell 3.68% for the week ended. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, December 12, 2014 where key benchmark indices dropped sharply on weak global cues. The market logged declines in four out of five trading sessions in the week just gone by.
The S&P BSE Mid-Cap index fell 389.69 points or 3.71% to settle at 10,108.60. The S&P BSE Small-Cap index fell 406.21 points or 3.54% to settle at 11,068.48. The fall in these two indices was lower than the Sensex's decline in percentage terms.
In the week ended Friday, December 12, 2014, the 30-share S&P BSE Sensex lost 927.42 points or 3.26% to settle at 27,350.68. The 50-unit CNX Nifty lost 314.20 points or 3.68% to settle at 8,224.10.
Weekly market trend from December 08 - December 12:
December 08- Indian shares posted their biggest fall in 7-1/2 weeks on Monday as IT services exporter Infosys Ltd slumped after its founders sold the company's stock, while metals and mining firms tumbled on data showing an unexpected fall in imports to China. The S&P BSE Sensex and CNX Nifty ended 1.19%-1.17% lower each. The 30-share Sensex ended down 339 points at 28,119 and the 50-share Nifty closed 100 points lower at 8,438. The Sensex and the Nifty touched an intra-day low of 28,097 mark and 8,432.
December 09- Indian shares fell for the second consecutive day on Tuesday, down to their lowest in one month, as investors cashed out tracking a selloff in Chinese markets and hurt blue-chips such as Oil and Natural Gas Corp. The S&P BSE Sensex and CNX Nifty ended 1.15%-1.16% lower each. The 30-share Sensex ended down 322 points at 27,797 and the 50-share Nifty closed down 97 points at 8,341.
December 10- Indian shares rose on Wednesday, recovering from one-month lows and snapping a three-day losing streak, as recent underperformers such as State Bank of India gained on value-buying while a firmer trend across the region also helped. The 30-share Sensex gained 34 points to end at 27,831 and the 50-share Nifty surged 15 points to close at 8,356.
December 11- Indian markets fell on Thursday for a fourth session in five, with oil explorers leading the decline as global crude prices continued their recent tumble, while blue chips such as Infosys fell on profit-taking. The Sensex ended 229 points down at 27,602 and the Nifty ended 63 points lower at 8,293
 December 12- India's NSE index fell for a fifth session in six on Friday to post its worst weekly loss since July as oil explorers continued to slump after Brent crude prices slipped to below $63 a barrel. The 30-share Sensex ended down 251 points or 0.91% at 27,351 and the Nifty closed 69 points or 0.8% lower to end the trade at 8,224.
Global indices:
Majority of the Global Indices closed in negative territory, barring Shanghai Comp which was up by 0.02%. Topmost losers: CAC40 down 4.38%, FTSE 100 down 4.17%, Hang Seng down 3.14% and Nikkei down 3.06%.
 Sectoral and stock screening:
All sectors ended in red except S&P BSE HC up by 0.11%. Topmost losers: S&P BSE Oil & Gas fell by 7.26%, S&P BSE CG fell 7.23%, S&P BSE Realty fell 7.20%, S&P BSE Metal fell 5.91% and S&P BSE Power 5.71%.
| | Looking at the 'A' group stocks, the top three gainers of the week were - Ajanta Pharma up by 6.44%, Wockhardt up by 4.62% and Bajaj Finance up by 3.36%
Top three losers of the week were - Sunrise Asian down by 17.67%, Havells India down by 17.29% and India Cements down by 16.56%.
FII/MF activity:
The foreign institutional investors (FIIs) have been the net buyers of the Indian stocks to the tune of Rs4718.32 crore and the domestic investors bought Indian shares worth a net of Rs164.5 crore as on December 10, 2014.
| | TOP MOVERS (GROUP A) |  | | | | | | | | Ajanta Pharma | 2697.00 | 6.44% | | | | | Bajaj Finance | 3300.00 | 3.36% | | | | | Sunrise Asian | 402.95 | -17.67% | | | Havells India | 265.75 | -17.29% | | | India Cements | 78.60 | -16.56% | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 15,624.86 | 1,852.50 | | | Gross sale | 10,906.54 | 1,688.00 | | | Net investment | 4,718.32 | 164.50 | | | | | | | | | Data as on December 10, 2014 | | | | Market Outlook for the coming week!
In the coming week, wholesale price index (WPI) inflation data for November 2014, corporate advance tax for the third installment of 15 December and developments in the ongoing winter session of parliament are the domestic factors that will be closely watched during the forthcoming week.
Among global cues, all eyes will be on the outcome of the Federal Open Market Committee (FOMC) monetary policy review and snap election in Japan and Greece's presidential elections.
Apart from domestic and global economic data, trend in global markets, investment by foreign portfolio investors (FPIs), the movement of rupee against the dollar, and crude oil price movement will dictate near term trend on the bourses.
The government will release the inflation data based on wholesale price index (WPI) for November 2014 on Monday, (December 15, 2014).
Corporate advance tax payment for the third installment which is due on Monday, (December 15, 2014), could provide clues on Q3 December 2014 corporate earnings.
Shares of PSU OMCs will be in focus as these companies will review fuel prices on Tuesday, (December 16, 2014 based on the average imported oil price in the preceding fortnight.
The Indian government is likely to introduce the constitutional amendment bill for the goods & services tax during the ongoing winter session of parliament. The government also plans to bring the MMDR Amendment Bill, 2014 during the ongoing winter session of parliament.
The Federal Open Market Committee (FOMC) next undertakes monetary policy review at a two-day meeting on Wednesday, (December 16, 2014) and Thursday, ( December 17, 2014). The policy meeting will be keenly watched for any hints on the timing of interest rate increases in the world's biggest economy. | | | | To know more about our products and services, click here. |  | Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Fax: 67481899; E-mail: publishing@sharekhan.com; Website: www.sharekhan.com; CIN: U99999MH1995PLC087498. Sharekhan Ltd.: SEBI Regn. Nos. BSE- INB/INF011073351 ; CD-INE011073351; NSE- INB/INF231073330 ; CD-INE231073330; MCX Stock Exchange- INB/INF261073333 ; CD-INE261073330; DP-NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN." | | | |
|
posted by Anonymous @ 7:31 AM  |
|
| 1 Comments: |
-
We are a gaggle of volunteers and opening a new scheme in our community.
Your site provided us with useful info to work on. You have performed an impressive task and our whole group will be grateful to you.
NCDEX Tips
|
| |
| << Home |
|
|
|
|
We are a gaggle of volunteers and opening a new scheme in our community.
Your site provided us with useful info to work on. You have performed an impressive task and our whole group will be grateful to you.
NCDEX Tips